Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT07327957
Active, not recruiting Not applicable

Effects of Vibration and Breathing Exercises on Pain and Anxiety During Chest Tube Removal

NCT07327957 · tracked via the Priya Life Science Turkey tracker
Sponsor
Gamze BULUT
Phase
Not applicable
Started
2026-06-15
Last updated
2026-07-23

Condition(s) studied

Postoperative PainAnxietyThoracic Drainage

Investigational drug(s) / intervention(s)

VibrationBreathing Exercises

Vibration: Vibration will be applied using a portable data device inserted for a standard duration, combined with chest tube placement. The procedure will be performed with the patient in a comfortable position.

Breathing Exercises: The remaining patients will be given breathing exercises including slow, deep, diaphragmatic, and iced-lip breathing techniques. These exercises will be performed calmly and quietly by the researcher to promote relaxation. The combined intervention will continue in addition to routine clinical care until the procedures and chest tube removal expense are completed.

Study summary

Removing a chest tube is a common procedure after chest surgery, but it can cause significant pain and anxiety for patients. Although medications can help reduce these symptoms, they may have side effects and are not always sufficient. Therefore, simple and safe non-drug methods are increasingly used to improve patient comfort.

This randomized controlled study aims to examine the effects of vibration and breathing exercises applied before chest tube removal on patients' pain and anxiety levels. Adult patients with a chest tube will be randomly assigned to one of three groups: a vibration group, a breathing exercise group, or a control group receiving standard care. Pain and anxiety levels will be measured before the procedure and after chest tube removal using validated scales.

The findings of this study are expected to show whether vibration and breathing exercises are effective in reducing pain and anxiety during chest tube removal. If effective, these methods may offer nurses an easy, low-cost, and safe way to improve patient comfort and support evidence-based nursing care.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion criteria * 18 years of age and older, * Conscious, oriented, and cooperative (e.g., Glasgow Coma Score ≥ 13), * Able to speak and understand Turkish, * Having a chest tube and undergoing chest tube removal for the first time, * Hemodynamically stable, * Having not taken analgesic, sedative, or anxiolytic drugs at least 4 hours prior to the procedure, * Able to communicate and respond to pain assessment scales during the procedure, * No severe hearing, visual, or communication impairment, * No neurological or cognitive disease that could affect the assessment of cognitive functions, * No history of psychiatric diagnosis or active psychiatric treatment, * Patients who voluntarily participate in the study and provide written consent will be included. Exclusion criteria * Patients with past or current cognitive and psychological disorders, * Those who have previously had chest tube insertion, * Those who are mechanically ventilated (intubated), * Those who have chronic pain and routinely use analgesics, * Those who used analgesics immediately before chest tube removal, * Those who did not volunteer to participate in the study.

Primary outcome measure(s)

  • Pain Intensity — Assessed immediately before chest tube removal and 10 minutes after the procedure.
    Pain intensity associated with chest tube removal will be assessed using the Visual Analog Scale (VAS), a validated 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will self-report their pain level.

Trial sites (1)

FacilityCityRegionStatus
Atatürk Universty Erzurum Erzurum

More Gamze BULUT trials in Turkey

Hologram Burn Dressing on Pain, Anxiety, Fear, Patient Satisfaction, and Physiological Parameters Active, not recruiting

Other trials for the same condition

"Erectile Function After PCI in MI and Non-MI Patients" Recruiting
SPSIP vs ESP Block for Analgesia After Rib Fracture Surgery Starting soon
FRONT Block for Quality of Recovery After Total Hip Arthroplasty Recruiting
S-TAP vs RSB in Midline Abdominal Incision Laparotomy Active, not recruiting
Comparison of TAP Block and Umbilical Paramedian Linea Semilunaris Block in Pediatric Laparoscopic Surgery Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07327957 on ClinicalTrials.gov ↗ ← All trials in Turkey